PDE4A and neoplasm: Finally, we demonstrate that cocktail of forskolin, probenecid (pan-MRP inhibitor) and rolipram (PDE4 inhibitor) effectively inhibit in vitro cell growth and in vivo tumor development of TNBC cells.